MedPath

Assessment of Starch Digestibility and Amylase Sufficiency in Children

Not Applicable
Completed
Conditions
Malnutrition, Child
Interventions
Other: Normal sorghum porridge, algal starch
Other: Normal sorghum porridge, algal dextrins
Other: Normal sorghum porridge, labeled flour
Other: Modified sorghum porridge, labeled flour
Other: Thinned sorghum porridge, labeled flour
Other: Modified sorghum porridge, octanoic acid
Registration Number
NCT03467737
Lead Sponsor
Purdue University
Brief Summary

Research has demonstrated that there is a relationship between malnourishment and insufficient production of pancreatic enzymes, such as α-amylase which digests starch into glucose. Starchy foods that can be easily digested into glucose are critical to the development child for energy and proper growth. This study investigated the use of a noninvasive breath test for the assessment of amylase sufficiency, digestibility of normal and modified sorghum porridges and gastric emptying rate of a sorghum porridge in Malian and U.S. children.

Detailed Description

The purpose of this research is to test the hypotheses that: 1.) Moderately malnourished stunted children have low pancreatic α-amylase activity; and 2.) Modified starchy food preparations will have better (higher) digestibility than the commonly given foods for both moderately malnourished stunted and healthy non-stunted children. A noninvasive breath test was used to assess amylase insufficiency in moderately malnourished and stunted children in Mali, as well as in healthy children in Mali and the United States. Moderately malnourished and healthy children in Mali were fed sorghum porridges, which are commonly consumed in Mali. Porridges contained a 13C-labeled substrate (algal starch or octanoic acid) for assessment of amylase insufficiency and gastric emptying rate. In a follow-up study, healthy children in the United States were also assessed for amylase sufficiency.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Stunted weaned children in the age range 18 - 30 months with height-for-age Z-score (HAZ) below -2 (HAZ<-2)
  • Healthy, weaned children 18-30 months of age for study 1
  • Healthy, weaned children up to 5 years old
Exclusion Criteria
  • Acutely ill and wasted child with weight for height lower than -2 z-score
  • No medical problems other than their malnutrition status
  • No medications

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Normal sorghum porridge, algal starchNormal sorghum porridge, algal starchSorghum porridge with 13C-algal starch
Normal sorghum porridge, algal dextrinsNormal sorghum porridge, algal dextrinsSorghum porridge with 13C-algal starch limit dextrins
Normal sorghum porridge, labeled flourNormal sorghum porridge, labeled flourSorghum porridge with 13C-labeled sorghum flour
Modified sorghum porridge, labeled flourModified sorghum porridge, labeled flourModified sorghum porridge with 13C-labeled sorghum flour
Thinned sorghum porridge, labeled flourThinned sorghum porridge, labeled flourModified thinned sorghum porridge with 13C-labeled sorghum flour
Modified sorghum porridge, octanoic acidModified sorghum porridge, octanoic acidModified sorghum porridge with 13C-labeled octanoic acid
Primary Outcome Measures
NameTimeMethod
Gastric emptying3 hours after being fed test meal

Breath test using 13C-tracer in octanoic acid was used to assess gastric emptying in healthy and moderately malnourished children

Alpha-amylase sufficiency in children3 hours after being fed test meal

Breath test using 13C-tracer was used to assess alpha-amylase sufficiency in healthy and moderately malnourished children

Starch digestibility3 hours after being fed test meal

Breath test using 13C-tracer in labeled sorghum flour was used to assess starch digestibility of three different prepared sorghum porridges of different thicknesses in healthy and moderately malnourished children

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath